Skip to main contentSkip to main content
info@smcsalud.org
Educational Guide

Diabetic Foot Limb Preservation

An educational guide for families and caregivers exploring limb preservation options for diabetic foot complications. Our multidisciplinary team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. Information only, not medical advice.

Heberprot-P therapy For US families & caregiversNot available in the US
38.4M
Americans with diabetes (2024)
15%
of diabetics develop foot ulcers
$409B
Annual US diabetes care cost
4–8 wks
Cuba program cycles (individualized)

Educational Resource — Not Medical Advice

The information on this page is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with your qualified healthcare provider before making decisions about treatment options.

We do not target, identify, or retarget individuals based on health conditions. This content is intended for families and caregivers seeking information about international treatment options, and is discoverable through organic search.

Understanding Limb Preservation

What Limb Preservation Means

Limb preservation is a comprehensive approach to healing diabetic foot wounds and avoiding amputation whenever medically possible. It combines intensive wound care, circulation restoration, infection management, and advanced therapies in a coordinated, multidisciplinary effort.

Comprehensive Wound Care

Daily specialist attention, debridement, advanced dressings, and offloading — far more intensive than typical weekly outpatient visits.

Circulation Restoration

Vascular assessment and revascularization procedures to restore blood flow, which is essential for wound healing and limb preservation.

Infection Elimination

Aggressive antibiotic therapy and surgical debridement to eliminate deep infection before it threatens the limb.

Advanced Therapies

Heberprot-P intra-lesional rh-EGF therapy, negative pressure wound therapy, and bioengineered tissue — options that may support healing in chronic wounds.

Multidisciplinary Team

Vascular surgeons, podiatrists, endocrinologists, infectious disease specialists, and wound care nurses coordinating care.

Individualized Assessment

Each patient is evaluated individually. Our team determines whether a limb-preservation program may be appropriate based on wound severity, circulation, infection status, and overall health.

Cuba's Approach

Cuba's Limb Preservation Program

Cuba has developed a comprehensive limb preservation program centered on Heberprot-P therapy combined with intensive, coordinated wound care. This approach is delivered as a residential program with daily specialist attention — a level of intensity that is difficult to achieve in standard outpatient settings.

Heberprot-P Therapy

Cuba's intra-lesional rh-EGF therapy, administered directly into chronic wounds to stimulate healing. Not available in the United States.

Daily Wound Care

Daily specialist attention to wound healing — not weekly appointments, but continuous, intensive care throughout the program.

Vascular Management

On-site vascular assessment and revascularization when needed, to restore blood flow to the affected limb.

4–8 Week Programs

Individualized program cycles with continuous monitoring, adjusted based on healing progress.

Multidisciplinary Coordination

All specialists — endocrinologists, podiatrists, vascular surgeons, wound care nurses — work together under one roof.

Aftercare Handover

A coordinated handover to your US physician with clinical reports and a monitoring plan for continued care at home.

Cuba's Approach

The Cuban Diabetic Foot Program

Cuba has developed a comprehensive diabetic foot treatment program centered on Heberprot-P — a recombinant human epidermal growth factor (rh-EGF) administered by intra-lesional injection directly into the wound. This therapy is combined with intensive, multidisciplinary wound care. Our team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. Heberprot-P is not available in the United States.

  • Heberprot-P intra-lesional rh-EGF therapy — a Cuban biotechnology innovation
  • Intensive daily wound care by specialist teams
  • Multidisciplinary team: endocrinologists, podiatrists, vascular surgeons, wound care nurses
  • 4–8 week individualized program cycles with continuous monitoring
  • Limb preservation focus — our team evaluates each patient individually
  • Coordinated aftercare and handover to your US physician

Heberprot-P®

Cuban biotechnology

Recombinant human epidermal growth factor (rh-EGF) developed by Cuba's Center for Genetic Engineering and Biotechnology (CIGB), administered by intra-lesional injection directly into diabetic foot wounds to stimulate healing.

4–8 Week Cycles

Multidisciplinary Team

Explore More

Diabetic Foot Care Resources

Explore our full range of educational diabetic foot care resources for US families and caregivers.

Your Journey to Cuba

From First Inquiry to Safe Return Home

01

Contact Us

Share your medical information and wound history through our inquiry form.

02

Free Evaluation

Our wound care team reviews your US records and designs a personalized plan.

03

Travel Coordination

We assist with e-Visa, flights, and accommodation in Cuba.

04

Treatment

Receive intensive wound care with Heberprot-P therapy and continuous support.

05

Aftercare

Coordinated handover to your US physician with a monitoring plan.

Frequently Asked Questions

Your Questions Answered

Submit Your Medical Records for a Diabetic Foot Evaluation

Our multidisciplinary team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. Share your medical records to receive a personalized assessment — often within 24–48 hours. No obligation, no travel required to get started.